Building our advanced mass spectrometry portfolio

We are actively developing new LC-MS/MS capabilities, with planned availability in Q1 2027. These investments are designed to expand our analytical service portfolio with advanced liquid chromatography–mass spectrometry technologies that support the detection, characterization, and quantification of complex analytes.

Once available, these capabilities will provide clients with access to high-sensitivity mass spectrometry solutions and automated workflows for small molecule and metabolite analysis.

scientist-woman-indicated-mass-spectrometry-results-from-analysis-differences-of-samples-shown-on-the-computer-in-the-laboratory

High-sensitivity LC-MS/MS systems

Advanced tandem mass spectrometry platforms designed to deliver exceptional sensitivity, selectivity, and confidence for trace-level detection and quantitative analysis.

Hybrid LC-MS platforms for complex analytes

Sophisticated liquid chromatography–mass spectrometry technologies intended to support the analysis of challenging compounds and complex sample matrices.

a-woman-scientist-at-mass-spectrometry-platform-in-a-laboratory
cutting-edge-technologies-used-in-proteomics-research-such-as-mass-spectrometry-protein-microarrays-and-bioinformatics-tools

Automated extraction workflows

Automated sample preparation and extraction workflows designed to improve efficiency, consistency, and throughput for small molecule and metabolite analysis.